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Background and Objectives: Gastro esophageal reflux disease (GERD) is believed to be important contributing factor in
many disorders of upper respiratory and alimentary tracts namely rhino-sinusitis nasal polyps , adenoid enlargement ,
chronic tonsillitis , chronic pharyngitis , chronic esophagitis , esophageal strictures , chronic laryngitis , otitis media , and
chronic chest infections . It has been reported that GERD and Helicobacter pylori (HBP) infection may be interrelated
phenomenon. Although there are many theories tried to explain the pathogenesis of GERD but still Helicobacter pylori
based theory is considered as strong theory via which the GERD pathophysiological mechanism factor can be presented.
The successful eradication of Helicobacter pylori infection was shown to be significantly related to improvement of the
symptomatology in patients with chronic upper air way and alimentary tract related disorders. Therefore this study was
conducted prospectively to confirm this concept specifically in relation to the incidence as well as the management of
chronic sinusitis.
Patients and Methods: 235 patients aged 5-85 years with already confirmed GERD at different grades according to
(Savary- Millar or Savary- Monnier 1989) grading system on bases of diagnostic upper gastrointestinal tract fibrooptic
endoscopic evaluating examination presented at internal medicine department and ENT department, Althwora-hospital,
Elbedya- Libya with varieties of upper aero-digestive related symptoms at period from September 2005 up to March 2009
were studied as prospective study .All patients were investigated for H.pylori infection by using of ELISA as serological
test to demonstrate anti-helicobacter pylori antibodies titer before the starting of the recommended medication and
compared with results at the end of the course by 4-6 months. The results were correlated with the clinical presentations
of the patients. Results:
208 patients (89%) of the total number showed positive Helicobacter pylori and 203 cases (98%) were improved after
medical eradicative course against Helicobacter pylori . on the other hand only 27 patients (11%) with either upper air
way or alimentary tract related disorders in association with chronic infective rhino-sinusitis were found to be with a
negative Helicobacter pylori results .
Conclusion: The Para nasal sinus disease is considered as one of ENT related common presentation in GERD. I.e. GERD
can be described as one of predisposing factors of sinopathy. It is well known that, there is strong correlation between
GERD pathogenesis and HBP infection. In the same time there is well –established significant relationship between GERD
and Para nasal sinus disease. Therefore, as it was confirmed in this presenting study that the HBP infection may act as
main predisposing factor for sinus pathology among patients with GERD.
Keywords: GERD, HELICOBACTER PYLORI, chronic rhino-sinusitis.
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INTRODUCTION
Gastro esophageal reflux disease (GERD) is believed to be
important contributing factor in many disorders of upper
respiratory and alimentary tracts. It is the most common
esophageal disorder.(1) GERD is patho-physiologically
developed due to defect in one or more than one of the
normal anatomical or physiological control mechanism
factors of the reflux phenomenon resulting in the
exceeding of normal reflux index and thus the appearance
of the clinical presentation of the disease. reflux index is
considered as time factor of reflux phenomenon
occurrence per 24 hours which must be normally not
exceeding five minutes.(2) Therefore , if the total duration
of reflux process is more than the normal upper limit this
leading to the induction of reflux disease process and the
appearance of GERD symptomology.(3) The defect in
reflux index can be due to anatomical predisposition as
lower esophageal sphincter weakness, cardio-phrenic
angle anatomical disorders, increasing of the abdominalthoracic pressure gradient, and phrenoesophageal
ligament weakness, and/or physiological predisposition
as increasing in gastric secretion rate , defect in gastric
acid clearance which can be due to defect in esophageal
mobility , defect in salivary basic secretions , and/or
defect in esophageal mucosal bridges regeneration and
secretions.(4) There are different theories tried to discuss
the pathogenesis of the excessive promotion of gastric
acid secretions . The most important theories are biliary
system disorders based theory, cyclooxygenase -2 (COX-2)
enzyme based theory, and helicobacter pylori infection
based theory.(5)
Helicobacter pylori play an important rule in the
pathogenesis of GERD.(6) It was isolated from different
places of alimentary as well as respiratory tract of patients
who were diagnosed as GERD.(7) Among those patients,
the control of the clinical conditions was directly
proportionally to the eradication of the bacteria.(8)
H. pylori is a gram negative microaerophilic, rod-shaped
bacteria approximately 0.5nm in diameter and 3-5nm
long. (9). H. pylori has 4-7 polar-sheathed flagella, which
enable the bacterium to move freely in viscous
environment such as gastric mucus. This motility is
essential for the bacterial colonization of its host. The
flagella sheath is a membrane containing protein and lipo
-polysacharides which probably protects the flagella
filaments from gastric acidity.(10) It is well recognized that
stomach is the natural niche for H. pylori.
H.pylori can grow depending on the culture medium over
a wide rang of pH 5.5-8.5 with good growth between pH
6.9 and 8.(11) Helicobacter pylori infection is usually
acquired in childhood and persists for life unless
specifically eradicated; yet, it can emerge after
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eradication.(12) In developing countries, the major risk
factor for acquiring H. pylori infection is poor
socioeconomic condition during childhood. Therefore
prevalence of H. pylori infection can be greater than 80%
in children less than 10 years old and up to 90% in
adult.(13) In contrast children develop few infections in
developed countries occurs during childhood. A gradual
increase in prevalence is observed with age with infection
rates of 20-30% by age of 20 and of about 50% at 50-60
years.(14) Poor socioeconomic condition during early
childhood as measured by household crowding and
parental income are thought to play some role in H. pylori
infection.(15) There is evidence that countries with poor
sanitation have greater infection rates which suggests a
common water source as the reservoir rather than person
to person transmission. There is a strong correlation
between consumption of municipal water and H. pylori
infection in some countries. Recent data suggest that a
bacterium is present in river water and drinking water.(16)
H.pylori was significantly higher in males than females. It
was found that smoking did not cause ulcer in absence of
H. pylori infection.(17) The genetic factors may influence
disease prevalence, however, as evidenced by H. pylori
concordance being higher in monozygotic than dizygotic
twins.(18) The sources and routes of transmission have not
been definitively established despite numerous studies
which suggest that faecal-oral and oral-oral transmission
of H. pylori is most likely.(19) In addition to gastric
specimens, detection of H. pylori from different regions
such as oral region suggests that bacterium may lead to a
broad spectrum of clinical manifestations and may be the
cause of the high incidence of H. pylori infection in the
world.(20) Recent data showed that H. pylori was
associated with extra gastric disorders such as coronary
heart
disease,
rosacea,(21)
glaucoma(22)
chronic
rhinosinusitis(23) and squamous cell carcinoma of the head
and neck.(24) Compared with control subjects, a
significantly higher prevalence of H. pylori in patients
with these disorders were documented. Other evidence
regarding the association of H. pylori with these disorders
was the improvement in the conditions of some patients
after eradication of H. pylori.(25) Several clinical
observation suggest role for H. pylori infection in various
immunological disorders. Some reports have shown
healing of some autoimmune disease such as henochschonlein
purpura
Sjogren’s
and
autoimmune
thrombocytopenia after eradication of H. pylori.(26)
Furthermore, the observation of complete disappearance
of some cases of extra gastric mucosa associated lymphoid
tissue (MALT) lymphoma, such as those localized to the
salivary gland, small intestine and rectum, following
treatment for H. pylori infection is of special interest.(27)
Some studies have suggested a link between idiopathic
chronic urticaria and H. pylori infection. Acne rosacea and
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alopecia areata have also been associated with H. pylori
infection.(28) H. pylori infection is reported to be more
highly present in patients with sideropenic anaemia
compared with healthy controls.(29) At least 25
epidemiological studies have been published on the
association between H. pylori antibody titer and ischemic
heart disease.(30) More recently, it has been suggested a
pathogenic role of the H. pylori chronic infection in
migraine, based on a relationship between the host
immune response against the bacterium and the
alterations of vascular permeability as a result of chronic
release of vasoactive substances; superoxide radicals and
nitric oxide during the infection.(31) It is confirmed that
focal T-cell mediated immunity (delayed type of
hypersensitivity reaction or a cytotoxic response) is the
mechanism- ultimately responsible for tissue destruction
in the recurrent aphthous ulcer.(32) It had been suggested
that this mechanism is induced by H.pylori infection.(33)
Recently. a high prevalence of H. pylori infection has been
recognized in patients with chronic open angle glaucoma.
H. pylori infection may influence the pathophysiology of
glaucoma by releasing various vasoactive substances.(34)
H.pylori was shown in the upper aero digestive tract in
several studies; this indicates that it might be related to the
pathogenesis of various ear, nose and throat diseases. H.
pylori were detected in the nasal and sinus mucosa of
patients with chronic sinusitis which indicates a possible
role in pathogenesis of chronic sinusitis.(35,36) Furthermore,
H. pylori were detected in nasal polyp tissue. The
mechanism by which H. pylori reaches the nasal cavity
can be explained by three possibilities. First, the nasal
cavity may be a reservoir of H. pylori. Second, the oral
cavity may represent the reservoir of H. pylori and the
microorganisms may come to the sinonasal cavity by way
of the oronasal reflux. Third, the stomach may be the
primary reservoir of this infection, and transmission of H.
pylori from the stomach to the nasal cavity might occur by
way of Gastroesophageal reflux (GERD).(37) However
reflux is believed to be an important contributing factor in
many disorders of the upper respiratory tract particularly
sinusitis.(38) Although the mechanism of how the GERD
causes sinusitis is unclear, but there are many suggested
direct- local theories which tried to explain the possibility
of the pathogenesis of the sinusitis on top of GERD: 1) the
change of the normal PH value of the Para nasal sinuses,
which will result in the over growth of the opportunistic
micro-organisms. 2) Interference with the normal mucociliary clearing mechanism. 3) The stimulation of the over
mucosal secretions which leading to more mucosal
stagnation. 4) The obliteration of the normal para nasal
sinuses ostia drainage. And 5) The destruction of the
normal mucosal contour.(39) On the other hand, the GERD
induced sinusitis was claimed to be as a sequel of the
ascending spread of the infection form already existing
tonsillitis, laryngo-pharyngitis, stomatitis, and rhinitis.(40)
Chronic pharyngitis may be related to H pylori infection.
The infection rate with H.pylori in the pharynx is higher
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in patients with stomach ailment histories than in patients
without stomach ailment histories.(41) In recent years,
gastroesophageal reflux has been increasingly associated
with chronic middle ear problems but the underlying
mechanism is unclear.(42) The demonstration of H. pylori
in the middle ear indicates that gastric contents reach the
middle ear due to reflux and supports that reflux and H.
pylori may be involved in the pathogenesis of OME
resistant to medical treatment. However, it may be
postulated that H. pylori may cause secretory hyperplasia
in the middle ear just as it does in the gastric mucosa.(54)
Tasker et al(43) determined higher concentration of pepsin
and pepsinogen in the middle ear than serum of patients
with OME indicating that gastric juice could reach as far
as middle ear.(44) If gastric juice could enter the middle ear,
H.pylori a common inhabitant of gastric juice and mucosa
in patients with peptic ulcer and chronic gastritis, would
also be expected to be found in the middle ear of patients
with OME.(45) Reflux of gastric content from the
nasopharynx into the middle ear is, possibly, due to the
angle of the immature eustachian tube this would cause
inflammation of the nasopharynx and eustachian tube,(46)
thus disturbing eustachian tube clearance, therefore
causing the nasopharyngeal bacteria to enter the middle
ear. H. pylori may be one of such bacterium. Resolution of
OME with antibiotics also supports this hypothesis and in
the same time supports the concepts which were
hypothesed to explain the pathogenesis of chronic rhinosinusitis on top of GERD. In cases of sinusitis and OME
resistant
to
medical
and
surgical
treatment,
gastroesophageal reflux and H pylori infection should be
considered and evaluated.(47)
Various testes are available to diagnose H. pylori
infection. These testes can be categorized into those that
are based on direct assessment of biopsies specimens and
indirect tests that detect an immunological response (i.e
antibodies against H. pylori) or metabolic products
(urease activity) of H. pylori. The gold standared for the
detection of H. pylori has been defined as culture,
histopathological examination of biopsies spicemence or
serology, depending on the experience of investigator. In
order to optimize the diagnosis of H. pylori, it usually
recommended that several tests be used together.(48,49)
Biopsy specimen is required for (rapid urease test,
microbiological, histological and polymerase chain
rection( PCR assay).(50) On the other hand the indirect noninvasive tests will include The urea breath test which is
based on urease activity of the organism which liberates
carbon dioxide (C02) from urea and produces ammonia to
buffer its acidic environment.(51)
And several serological techniques have been used for the
study H. pylori infection (e.g. complement fixation
haemaglutination test, immunoblot, fluroimmunoassay)
but enzyme-linked immunosorbent assay (ELISA) is
currently consider the optimal serological method.(52)
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Eradication of Helicobacter pylori is defined as the
absence of the organisms for least a month after cessation
of medication.(53) Successful eradication of Helicobacter
pylori infection was shown to be significantly related to
improvement of the symptomatology in the patients with
chronic gastritis, duodenal and gastric ulcers and has been
even associated with regression of B-cell gastric
lymphoma.(54,55) .Helicobacter pylori can be eradicated
from the body with proton pump inhibitors with 2 or 3
antibiotic combinations for 2 weeks. With 3 (omeprazole,
clarithromycin,
amoxicillin
or
4
(omeprazole,
clarithromycin,
amoxicillin,
metronidazole)
drug
combinations, eradication rates of 75% to 88% or 80% to
99% can be achieved, respectively.(56)

PATIENTS AND METHODS
235 patients aged 5-85 years with already confirmed
GERD at different grades according to (Savary- Millar or
Savary- Monnier 1989) grading system on bases of
diagnostic upper gastrointestinal tract fibrooptic
endoscopic evaluating examination presented at ENT
department, Althwora central – teaching hospital, AlbydaLibya with varieties of upper aero-digestive related
symptoms in addition to suggested sinopathic chronic
headache at period from September 2005 up to March
2009 were studied as prospective study. Those patients
were evaluated via the history, clinical examination
including endoscopic examination as well as radiological
evaluation in form of CT-scan of Para nasal sinuses with
different views to confirm the chronic rhino-sinusitis.
Further, the patients were diagnosed with variable chronic
sinusitis related radiological finding, they were
investigated
for
H. pylori infection by using of ELISA as serological test to
demonstrate anti-helicobacter pylori antibodies titer before
the starting of the recommended medication and
compared with results at the end of the course by 4-6
months. The results were correlated with the degree of
improvement at clinical as well as radiological
presentations of the patients i.e. the patients' improvement
of their sinus disease was assessed by the history, local
examination, as well as CT-scan results and compared
objectively with pre-medication situations. Patients who
had used antacids, H2-blockers or antibiotics during the
month preceding the presentation, they are excluded from
the study. The patients were treated with specific
recommended regimen against the H. pylori infection. The
regimen was in form of oral administration of
combination of (clathramycin +omeprazole+ bismuth) for
4-6 weeks, in addition to local decongestant agents as well
as systemic analgesics.
An informed consent was taken from the patients or the
parents of the children involved in the research prior to
their participation.
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Data were expressed by using descriptive analysis as
means + standard error of mean (s. e. m) and percentages,
test of significance was carried out, using Chi-squar test
and two way analysis of variance.(3) A probability less
than 0.05 was considered as significant, the degree of
significance was determined by using level of standard
deviation test. Student -t- test was used for dependent
sample, as well as contingency coefficient was calculated
as measurement of association between nominal variables.

RESULTS
As shown in (Table I) there were 96 males and 139
females. The age distribution showed that 62% of cases
were > 40 years of age .On the other hand 23% of the
patients were of age <15 years (Table II) (P < 0.05).
Regarding the clinical presentation, the most frequent
clinical presentation was laryngeal related disorders
presentation (53%), followed by sinopathic related
symptomology (49%) , then aural and upper alimentary
tract related presentation (19%) as shown in (Fig. I).
As demonstrated in (Fig. II), in large number of cases
(89%) the patients had a positive ELISA test for H. pylori
infection with high significant rate (P < 0.01) as compared
with 27 cases with negative ELISA test. As postulated in
(Fig. III) there were different forms of radiological chronic
sinus pathologies. The titer of the anti-helicobacter
antibodies among the patients with positive ELISA is
significantly higher (9.135+0.24) than those with negative
ELISA test (0.782+0.008) (P < 0.01) as showed in
(Table III). Table IV presented significant reduction of
anti-helcobacter antibodies by 4-6 months from the end of
full recommended course of treatment (1.459+0.0327) as
compared with the initial titer prior to starting of
treatment (P < 0.01). This was correlated with chronic
sinusitis related clinical presentation as shown in (figureIV) which illustrated the significant improvement in sinus
related pathology by complete eradication of H. pylori
(P<0.005).

Table I. Sex distribution. (P < 0.05).
Sex

Males

Females

Total

No.

96

139

235

62.5

37.5

100

Percent

Table II. Age distribution. (P < 0.05).
Age

<15

15-40

40-85

No.

54

35

146

Percent

23

15

62
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Table III. ELISA results prior to the initiation of the
treatment: (P < 0.01).
Result

Positive
208

27

9.135+_0.24

0.782+_0.008

No.
Anti-body titer (mean +_S.D )

Negative

Table IV. ELISA results after 4-6 months after the
treatment: (P < 0.01).
Time of test

Prior to treatment

After treatment

9.135+_0.24

1.459+_0.0327

ELISA results
(mean +_S.D )

60
50
40
30
20
10
0

Fig 1. Relationship between GERD and sinus disease.
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27
208

Fig 2. Relationship between GERD and helico bacter pylori infection

= negative HBP,

= positive HBP).

60
50
40
30
20
10
0
thick .secr

thick .muco

cystic

polypoidal

Fig 3. Different pathological varieties of sinus disease.
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Fig 4. The degree of improvement regarding sinus pathology after complete eradication of HBP infection
(
= improved,
= not improved ).

DISCUSSION
Helicobacter pylori (H. pylori) is one of the most common
bacterial infections worldwide. Estimates suggest that
more than half of the world’s population is infected by
this gastric bacterium.(43) It is associated with chronic
gastritis and peptic ulcer diseases(39,44) and constitutes a
major risk factor for gastric adenocarcinoma and gastric
mucosa associated lymphoid tissue (MALT) lymphoma.(34)
Although the stomach is the natural reservoir of H. pylori
various tissues have been proposed as potential reservoirs
of infection such as tonsil, gingiva, dental plate,
gallbladder, para nasal sinuses, middle ear cavity, and
coronary arteries.(12)
The presence of H.pylori in the upper aero-digestive tract
has been investigated in more than 60 reports in the
English literature; some of them examine its presence in
the tonsils and/or adenoids by using various diagnostic
techniques showed that there was a high rate of H pylori
colonization in tonsillar and adenoid tissues however,
other indicated opposite results.(44,52,54)
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There are several methods (invasive and non-invasive)
available for detecting H. pylori infection. Invasive
methods are based on biopsy specimens as; Rapid urease
test, PCR,(47) culture staining biopsy materials with H&E
stain, Giemsa stain, Warthin-Stany silver stain,(56) and
stains which determine the macrophage iNOS (inducible
nitric oxide synthase) activity in tonsillar tissue.(29)
Non-invasive methods as; urea breath test,(40,41) stool
antigen test(52) and the enzyme linked immunosorbent
assay
(ELISA)
technique
to
identify
specific
immunoglobulin G antibodies against H. pylori in
serum.(53) When H. pylori was first found to colonize in
the upper respiratory tract, investigators used a single
diagnostic method to identify H. pylori infection.(24) In
more recent investigations, multiple tests have been used
comparatively in the same study.(55,56)
Smoot et al (2001) stated that the gold standard in
diagnosis of H. pylori infection is the direct identification
of the organism by two or more methods from Rapid
urease test, culture and histopathology. Ogata et al
considered a positive H. pylori infection by combining
three or more positive methods (Rapid urease test,
serology, histopathology, urea breath test).
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The present study was carried on 235 patients .Serum
samples from all patients were tested using the ELISA to
identify specific immunoglobulin G antibodies against H.
pylori. Serology test is used for diagnosis and follow-up
of H. pylori infection and for epidemiological studies.
Using ELISA, it is possible to measure anti-H. pylori
antibodies of different immunoglobulin classes, and
quantitative determinations are possible as well. The IgG
is positive in active infection and persists for 4-6 months
after eradication of infection.(30) It has been reported that
serologic testing with ELISA has a sensitivity of 95% and
specificity of 100 %.(41) 41% of cases were male while 59%
were female. Our findings are against the findings of
Blum 1996 who showed that ≥ 78% of cases were male.
This can be explained by male to female ratio in the
general Libyan population which is showing higher
female number as compared to the males. On the other
hand our study presented that the percentage of the
infection among the children is lower than that in the
adult. This is also not in accordance with Kuipers, et al
1993 and Imrie et al 2001. This can be explained by the
presentation of the children to pediatric department rather
than ENT or internal medicine department, resulting in
the missing of the pediatric cases.
Finally, as recommendation at any patient with chronic
sinusitis which is not associated with any local
abnormalities and not responding to conservative
treatment, we must exclude GERD . In addition if GERD
was confirmed, we must exclude HBP infection.
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